This is a generic. From the article: > Mulye also noted that rival pharmaceutical company Casper Pharma raised the price of its brand-name version of nitrofura

This is a generic. From the article: > Mulye also noted that rival pharmaceutical company Casper Pharma raised the price of its brand-name version of nitrofurantoin, called Furadantin. Casper hiked the price by 182 percent over three years—between 2015 and 2018—bringing a bottle’s list price to $2,800. There’s no ethical issue at all. It’s a purely a business issue of whether the market is worth competing in as a new supplier.